Peptoid ligands for isolation and treatment of autoimmune T-cells

Details for Australian Patent Application No. 2010253797 (hide)

Owner The Board of Regents of the University of Texas System OPKO Health, Inc.

Inventors Gocke, Anne R.; Udugamasooriya, D. Gomika; Kodadek, Thomas

Agent Pizzeys

Pub. Number AU-A-2010253797

PCT Pub. Number WO2010/138797

Priority 61/182,368 29.05.09 US; 61/260,608 12.11.09 US

Filing date 28 May 2010

Wipo publication date 2 December 2010

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

27 October 2011 PCT application entered the National Phase

  PCT publication WO2010/138797 Priority application(s): WO2010/138797

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010253815-Motor control module

2010253791-Antiviral compounds composed of three linked Aryl moieties to treat diseases such as Hepatitis C